✨ Free AI Report
Applied DNA Sciences, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Applied DNA Sciences, Inc.
Company Research

Applied DNA Sciences, Inc.: Business Overview, Financials & Competitive Analysis

Applied DNA Sciences is a biotechnology company commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets, now executing a yield-focused BNB digital asset treasury...

Analyst-debate audio for Applied DNA Sciences, Inc.

AskCyborg analysts argue the bull and bear cases for Applied DNA Sciences, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
3/ 10Weak

Cyborg Score thesis

A high-risk transformation play betting on cryptocurrency yield generation rather than sustainable biotech revenue...

Read the full analyst-debate transcript →
Industry Digital Asset Treasury Management / Cryptocurrency (formerly Biotechnology)
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Applied DNA Sciences, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Applied DNA Sciences, Inc. Overview

Pro stress-test →

Applied DNA Sciences is a biotechnology company commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets, now executing a yield-focused BNB digital asset treasury strategy. The company underwent a radical strategic pivot in October 2025, shifting from its traditional biotech operations to focus on cryptocurrency-based treasury management.

Strategic Profile

Pro stress-test →

The new ticker BNBX reflects the company's stated shift to a BNB-based digital asset treasury strategy focused on yield generation and token accumulation within the Binance ecosystem, pursuing an actively managed approach that integrates decentralized finance protocols and Binance-specific strategies. The company authorized a comprehensive corporate restructuring that includes a 60% workforce reduction (16 employees) and is expected to yield substantial annualized cost savings of approximately $2.9 million.

Competitive Landscape

Pro stress-test →

Applied DNA's traditional competitors in biotech DNA manufacturing (Zymergen, Ginkgo Bioworks) are now irrelevant following the company's strategic pivot. The company now competes in the crypto treasury management space against digital asset managers and DeFi protocols, an entirely different competitive landscape.

Industry Context

Applied DNA Sciences, Inc. operates in Digital Asset Treasury Management / Cryptocurrency (formerly Biotechnology).

Key facts

Founded: 1983 · Headquarters: Stony Brook, US · Employees: 27 · Revenue: $3.74M

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Applied DNA Sciences, Inc..

  • Radical strategic pivot to crypto treasury management with BNB focus, abandoning traditional biotech business model
  • 60% workforce reduction completed by October 2025, signaling major operational downsizing and cost restructuring
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • November 2025Company renamed to BNB Plus Corp.
  • October 2025Ticker symbol changed from APDN to BNBX; 60% workforce reduction completed
  • +1 moreTrack every material event for Applied DNA Sciences, Inc. as it happens. Explore monitoring →
Get alerted when Applied DNA Sciences, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Ginkgo BioworksSynthetic biology and DNA engineering (former competitor in biotech space)→ZymergenBiomanufacturing for biotechnology (former competitor in biotech space)→

Compare Applied DNA Sciences, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Applied DNA Sciences, Inc. operates in Digital Asset Treasury Management / Cryptocurrency (formerly Biotechnology). See how the rest of the sector scores on the Cyborg framework.

Browse Digital Asset Treasury Management / Cryptocurrency (formerly Biotechnology) research →
NEW · MCP server

Ask your AI assistant about Applied DNA Sciences, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Applied DNA Sciences, Inc. and its top competitor on Cyborg Score”
“What did Applied DNA Sciences, Inc. do this quarter?”
“Is Applied DNA Sciences, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Applied DNA Sciences, Inc. do?+
Applied DNA Sciences is a biotechnology company commercializing proprietary nucleic acid production solutions for the biopharmaceutical and diagnostics markets, now executing a yield-focused BNB digital asset treasury...
What is Applied DNA Sciences, Inc.'s Cyborg Score?+
Applied DNA Sciences, Inc. has a Cyborg Score of 3/10 (Weak). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Applied DNA Sciences, Inc.'s main competitors?+
Named competitors include Ginkgo Bioworks, Zymergen. The full competitive landscape is in the AskCyborg report.
How can I get the full Applied DNA Sciences, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Applied DNA Sciences, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Applied DNA Sciences, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.